Philippe Parone
Chief Scientific Officer Esobiotec
Seminars
Tuesday 24th February 2026
Strategic Matchmaking Roundtable Session: Connecting Innovators with Pharma, Investors, & C-Level Insights to Refine Partnership Readiness
1:30 pm
- Rotate through the tables to learn from Pharma and C-level executives with partnership experience, and gain practical insights to shape your future strategy
Thursday 26th February 2026
Pre-Clinical & Clinical Data Supporting Development of ENaBL: A Nanobody-Targeted, Immune-Shielded Lentiviral Platform for In-Vivo Cell Reprogramming
4:30 pm
- Key preclinical data supporting the engineered features of the ENaBL vector for T-cell reprogramming
- Present clinical data demonstrating the safety and efficiency of ENaBL’s in-vivo BCMA CAR-T reprogramming in patients with multiple myeloma
- Highlight key clinical outcomes on response rates, persistence, and safety profile compared to ex-vivo approaches
Tuesday 24th February 2026
Panel Discussion: Building Stronger Bridges Between Biotechs, Pharma & Investors
11:00 am
- Share how biotechs can present data and strategy in ways that help investors and pharma make faster, more confident decisions, reducing risk on both sides
- Highlight how pharma and investors can communicate expectations more clearly ensuring companies design studies and pipelines that are partner-ready
